Table 4 Division of mutations in clinical groups
From: Clinical, Molecular and Geographical Features of Hereditary Breast/Ovarian Cancer in Latvia
Diagnostic criteria | All cases | Examined cases | Number of BRCA1 mutation | Frequency of mutation |
|---|---|---|---|---|
HBC | 8 | 7 | 1 | 12.5% |
HBOC | 5 | 4 | 3 | 60.0% |
HBC susp. | 50 | 31 | 3 | 6.1% |
HBOC susp. | 8 | 6 | 2 | 25.0% |
HOC susp. | 2 | 1 | 0 | 0% |
2 Br, 1<50 | 1 | 1 | 0 | 0% |
CFA | 28 | 21 | 0 | 0% |
Others | 185 | 107 | 0 | 0% |
Total | 287 | 178 | 9 | 4.9% |